Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis.
about
Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathiesInflammation induced loss of skeletal muscleLong-term, high-dose intravenous immunoglobulin therapy in a patient with banker-type juvenile dermatomyositisHLA class II alleles may influence susceptibility to adult dermatomyositis and polymyositis in a Han Chinese populationDeveloping a provisional, international minimal dataset for Juvenile Dermatomyositis: for use in clinical practice to inform research.Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study.Purtscher-like retinopathy associated with dermatomyositisAdipokine gene expression in peripheral blood of adult and juvenile dermatomyositis patients and their relation to clinical parameters and disease activity measuresUpdate on management of connective tissue panniculitides.The clinical phenotypes of the juvenile idiopathic inflammatory myopathies.Oxidized mitochondrial nucleoids released by neutrophils drive type I interferon production in human lupus.Adult and juvenile dermatomyositis: are the distinct clinical features explained by our current understanding of serological subgroups and pathogenic mechanisms?The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.Chronic nonbacterial osteomyelitis in a child with previous juvenile dermatomyositisTreatment with high-dose recombinant human hyaluronidase-facilitated subcutaneous immune globulins in patients with juvenile dermatomyositis who are intolerant to intravenous immune globulins: a report of 5 cases.Consensus-based recommendations for the management of juvenile dermatomyositis.Idiopathic Inflammatory Myopathies: an Update on Classification and Treatment with Special Focus on Juvenile Forms.Adult dermatomyositis with bleeding ulcer in the pharynx.Vasculopathy-related clinical and pathological features are associated with severe juvenile dermatomyositis.Gene copy-number variations (CNVs) of complement C4 and C4A deficiency in genetic risk and pathogenesis of juvenile dermatomyositis.Dermatomyositis as presenting feature of ovarian cancer, treated with neo-adjuvant chemotherapy and interval debulking surgery.Development of a consensus core dataset in juvenile dermatomyositis for clinical use to inform research.Clinical efficacy of intravenous immunoglobulins for the treatment of dermatomyositis skin lesions without muscle disease.Accumulation of mature B cells in the inflamed muscle tissue of a patient with anti-155/140 antibody-positive juvenile dermatomyositis.Current management of juvenile dermatomyositis in Germany and Austria: an online survey of pediatric rheumatologists and pediatric neurologists.Development of practice and consensus-based strategies including a treat-to-target approach for the management of moderate and severe juvenile dermatomyositis in Germany and Austria.Dermatomyositis as a paraneoplastic phenomenon in ovarian cancer.
P2860
Q26863125-D6DB3ADD-1979-4540-A6D3-1352052E5045Q28083759-C5691EC0-74A6-4A4F-8153-F26A6FA2F07AQ33755333-3E614C7C-3140-4812-A1A6-EED3CA641B3CQ33772990-20139980-BA3D-4D32-AE99-F1B40EB64825Q33962448-D04D656D-1EC1-47A5-AC1F-A3BA4BFB9C02Q34486301-28BE52D8-B0F7-4D64-BBFE-012BF9B3BF95Q34862679-947442C6-520B-47B8-8FCC-D8CF031C3DB7Q35540694-2B3F1A12-F910-4906-81D9-C3A72F0258C7Q36073476-C39BA382-CD06-4089-9528-878CF23AB8C8Q36086954-FD805912-88CD-4196-8FE0-228A22F7FBA1Q36863168-3B28097D-5F0D-404F-B5E0-A4CEE07D7BA7Q36903076-63C9E9E3-DE7F-4DD1-8624-016F8BB7704EQ37040711-2839C827-6AC0-43FB-B954-E9E8B009E82CQ37183046-8EAAE879-F2B4-47DA-819F-E7F082C2212CQ37254849-BF501BDF-3117-40C9-BD32-E29635707FF2Q37617000-A2D61471-A78F-4F23-A5C6-10FF023981AAQ38597575-ADB0B7BC-8140-43F0-B5F7-77B0457D13B8Q40186268-B63FCFB2-DA99-48E8-868F-D69D9A5A8F58Q40479791-56C97282-5DE9-429B-9F81-33B1EA59D1C2Q41192731-BC6B0500-5FBE-4099-A2CB-66CC97AE260CQ42010588-07AEBCB4-B51B-41BF-AE51-069D42469000Q47689325-BE6EFA98-1614-404D-965A-65544F2BBE0BQ47882674-1A29DEF0-67AC-48CD-A83E-EF8A225E22C3Q50960491-868C7BEF-1DA5-4DCE-B27E-2873B17DAECEQ55284035-9302761D-CF6D-4626-A009-117DC39CED8DQ55512727-4A6D422E-8DFA-48AA-BB9C-544B7DF987E6Q55661809-85301907-470D-48BF-A830-FCEDA55BA0D3
P2860
Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis.
@en
Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis.
@nl
type
label
Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis.
@en
Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis.
@nl
prefLabel
Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis.
@en
Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis.
@nl
P2860
P356
P1476
Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis.
@en
P2093
Angela B Robinson
Ann M Reed
P2860
P2888
P304
P356
10.1038/NRRHEUM.2011.139
P407
P577
2011-09-27T00:00:00Z